Diabetic Macular Edema (DME)
Symptoms, Doctors, Treatments, Advances & More

Diabetic Macular Edema (DME) Overview

Save information for later
Sign Up

Learn About Diabetic Macular Edema (DME)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Diabetic Macular Edema (DME) Local Doctors?
Elite in Diabetic Macular Edema (DME)
Ophthalmology
Elite in Diabetic Macular Edema (DME)
Ophthalmology
Referral required
16661 Ventura Boulevard, Penthouse 900, 
Encino, CA 
Languages Spoken:
English
Accepting New Patients

David Boyer is an Ophthalmologist practicing medicine in Encino, California. Dr. Boyer is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy. Dr. Boyer is board certified in American Board Of Ophthalmology. Dr. Boyer is currently accepting new patients.

Elite in Diabetic Macular Edema (DME)
Ophthalmology
Elite in Diabetic Macular Edema (DME)
Ophthalmology
Referral may be required
10100 Katy Fwy, Ste 100, 
Houston, TX 
Languages Spoken:
English, Spanish, Vietnamese
Accepting New Patients

Charles Wykoff is an Ophthalmologist practicing medicine in Houston, Texas. Dr. Wykoff is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Diabetic Macular Edema (DME), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Wykoff is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Diabetic Macular Edema (DME)
Ophthalmology
Elite in Diabetic Macular Edema (DME)
Ophthalmology
Referral may be required

The Johns Hopkins Hospital

1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, 
Baltimore, MD 
Experience:
44+ years
Languages Spoken:
English
Accepting New Patients

Neil Bressler is an Ophthalmologist practicing medicine in Baltimore, Maryland. He has been practicing medicine for over 44 years. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Bressler is board certified in American Board Of Ophthalmology. Dr. Bressler is currently accepting new patients.

What are the latest Diabetic Macular Edema (DME) Clinical Trials?
An Operationally Seamless Phase 2b/3, Multicenter, Randomized, Masked, Sham-controlled Study to Evaluate the Efficacy and Safety of Surabgene Lomparvovec (Sura-vec) Delivered Via Suprachoroidal Space (SCS) Injection Targeting Subjects With Diabetic Retinopathy Without Center Involved-Diabetic Macular Edema (CI-DME) (NAAVIGATE)

Summary: Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood vessels in the back part of the eye (called the retina). Over time, this damage can lead to vision problems and even blindness if not treated. This study will assess surabgene lomparvovec (sura-vec) as a potential one-time gene therapy administered in the suprachoroidal space (SCS...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A First-in-human, Open-label (Part 1), Randomized (Part 2), Phase I/IIa Trial to Study Safety and Tolerability of Multiple Rising Intravitreal Doses of BI 3812465 in Patients With Center-involved Diabetic Macular Edema

Summary: This study is open to adults with diabetic macular edema that involves the center of the eye. The purpose of this study is to find out how well different doses of a medicine called BI 3812465 are tolerated by people with this condition. This is the first time BI 3812465 is given to humans. This study has 2 parts. In Part 1, a small number of participants receive low, medium, or high doses of BI 38...